Registration - Open from 9:00 am - Closes at 11:00 am
All delegates must complete their registration process before the 11:00 AM cut-off time. Please arrive in a timely manner to allow for registration and to avoid any inconvenience. Delegates who arrive after the registration deadline will be refused entry to the event.
We appreciate your cooperation in helping us maintain the event's schedule and ensuring that everyone can fully participate in the Pathology Conference. If you have any questions or require assistance, our event staff will be available to assist you with the registration process.
Thank you for your understanding, and we look forward to an insightful and productive event together!
Chair Opening Address (Confirmed)
- David Wells, Chief Executive, IBMS (Confirmed)
- Professor Dame Sue Hill, Chief Scientific Officer for England, Senior Responsible Officer for Genomics in the NHS (Invited)
- Dr Luke Moore, Faculty of Medicine, Department of Infectious Disease, Honorary Clinical Senior Lecturer (invited)
- Bernie Croal, President Elect of the Royal College of Pathologists (invited)
- Professor Sarah Coupland - RCPath Registrar; Senior Consultant Histopathologist; George Holt Chair of Pathology, University of Liverpool (Confirmed)
Overview:
In this dynamic panel discussion, we will delve into the forefront of pathology, exploring the intersection of various disciplines and the pivotal role they play in addressing contemporary challenges in healthcare.
Our expert panellists will lead discussions on four key themes shaping the landscape of pathology today: Antimicrobial Resistance (AMR), Molecular Services in Biochemistry, Lung Screening, and Genomics.
- Antimicrobial Resistance (AMR):
With the emergence of antimicrobial resistance as a global health threat, our panellists will explore the latest strategies and initiatives in pathology to combat AMR. From innovative diagnostic techniques to stewardship programs, the discussion will highlight the collaborative efforts needed to mitigate the impact of resistant pathogens on patient outcomes and public health.
- Molecular Services in Biochemistry:
Advancements in molecular diagnostics are revolutionizing the field of biochemistry, enabling more precise and personalised approaches to patient care. Our panellists will examine the integration of molecular techniques into routine laboratory practice, discussing their implications for disease detection, prognosis, and treatment selection across a spectrum of conditions.
As lung cancer remains a leading cause of cancer-related mortality worldwide, effective screening strategies are imperative for early detection and intervention. Our panel will explore the role of pathology in lung cancer screening programs, emphasising the integration of innovative imaging modalities, biomarkers, and histopathological assessment to optimize patient outcomes and reduce mortality rates.
The advent of genomic technologies has ushered in a new era of precision medicine, offering unprecedented insights into the molecular basis of disease. Our panellists will explore the evolving landscape of genomic pathology, from applications in oncology and rare diseases to the challenges and opportunities associated with large-scale genomic data interpretation and integration into clinical practice.
Through engaging discussions and real-world case studies, this panel aims to foster interdisciplinary collaboration, inspire innovation, and empower pathology professionals to navigate the complexities of modern healthcare delivery effectively.
Join us as we explore the synergies between different pathology disciplines and chart a course towards a healthier future for all.
Headline Sponsor - Source LDPath
Chair Morning Reflection (Confirmed)
Case Study - Exponential-e
‘Fireside Chat’ re MES Procurement Approach
Chair Afternoon Address (Confirmed)
- Chris Sleight, Chief Officer - Greater Manchester Diagnostics Network - Trust Provider Collaborative (Confirmed)
- Bee Anthony, Operational Director, East Suffolk and North Essex Diagnostic Network (Invited)
- Simon Brewer, Managing Director SWLP (Confirmed)
- Branko Perunovic, Chief Medical Officer, Black Country Pathology Service | Histopathology (Provisionally Confirmed)
- Francesca Trundle. Managing Director. Kent and Medway Pathology Network. Kent and Medway Pathology (invited)
- Bruce Daniel, Head of Pathology, SW Region at NHS England (invited)
- Supriya Joshi, Clinical Director, Kent and Medway Pathology Network (Confirmed)
Overview:
In this Mini Quick-Fire Panel Discussion, we bring together a prominent network of pathology experts to share insights, exchange best practices, and collaboratively address pressing issues facing the field.
This dynamic session will feature rapid-fire discussions and Q&A, allowing attendees to gain valuable perspectives and practical solutions in a condensed timeframe.
Key Topics:
- Laboratory Management: Efficient workflows, resource optimisation, and operational strategies for enhancing productivity and quality assurance.
- Quality Assurance: Best practices for ensuring accuracy, reliability, and compliance in laboratory testing processes.
- Emerging Technologies: Exploration of cutting-edge technologies and their applications in pathology, including AI, digital pathology, and molecular diagnostics.
- Patient Care Strategies: Innovative approaches to patient-centred care, personalised medicine, and interdisciplinary collaboration for improved clinical outcomes.
- Challenges and Solutions: Identification and discussion of common challenges encountered in pathology practice, with collaborative brainstorming for effective solutions.
- Future Directions: Insights into emerging trends, opportunities, and areas for growth and advancement within the field of pathology.
Through brief yet impactful exchanges, attendees will have the opportunity to glean actionable insights and innovative approaches to common challenges encountered in pathology practice.
Case Study - Profilerlive
- Matthew Connell, Director of Digital, Data and IT at Northwest London Pathology (Confirmed)
- Kerman Jasavala, Associate Partner at IBM (invited)
- James Davis, Founder, CEO at Inicio Health (invited)
- Ruth Holland, Deputy CIO, Imperial College (invited)
Overview:
As we wrap up this enlightening event, we invite you to a captivating panel discussion exclusively focused on the future of pathology services. Delving into the realm of cutting-edge technology and innovation, this session promises to offer a compelling vision of what lies ahead for pathology practice.
Key Topics:
- Digital Pathology Revolution
- Artificial Intelligence in Diagnostics
- Next-Generation Sequencing
- Telepathology and Teleconsultation
- Lab Automation and Robotics
- Data Analytics and Predictive Modelling
Through insightful discussions and visionary perspectives from our panel of experts, attendees will gain valuable insights into the transformative potential of these technological advancements in shaping the future of pathology services.
Join us as we embark on an inspiring journey into the frontiers of innovation, paving the way for a more efficient, accurate, and patient-centred approach to pathology practice.
Canapés, Drinks and Networking
